MCCULLOCH KEVIN (See Remarks) sold 0.9% of their position (15K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market sale worth $120.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/4/2026ACC: 0001867096-26-000059
Officer· See Remarks
Since Mar 2026
-15K
Net shares
Net seller
$120.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
15K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−15K
Price / share
$8.02
Trade value
$120.24K
% of position
0.9%
8/3/2026
1.69M→1.68M
Total
Net shares
−15K
Net value
-$120.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/3/2026 | S · Sale | −15K | $8.02 | $120.24K | 0.9% | 1.69M | 1.68M |
| Total | −15K | -$120.24K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned25K
Total
25K indirect25K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 25K | Indirect |
| Total | 25K | 25K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported